Deloitte Survey Finds AI’s Return On Investment Lags Expectations

 
• By Joseph Haas
  
AI is the buzz word in biopharma but are results meeting expectations? (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip